BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$672M |
| 2 |
Microsoft
MSFT
|
+$541M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$441M |
| 4 |
Pfizer
PFE
|
+$425M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$805M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$535M |
| 3 |
Lam Research
LRCX
|
+$482M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$359M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.25% |
| 2 | Financials | 7.39% |
| 3 | Consumer Discretionary | 7.31% |
| 4 | Healthcare | 6.72% |
| 5 | Communication Services | 5.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Farmers & Merchants Bancorp
FMAO
$486M
| $78.5K | ﹤0.01% |
2,839
+306
| +12% | +$7.87K |
|
|
CNSL
3377
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $78.3K | ﹤0.01% |
16,868
+1,252
| +8% | +$5.69K |
|
3378
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.29B
| $77.7K | ﹤0.01% |
4,306
+4,299
| +61,414% | +$75.9K |
|
3379
Tejon Ranch
TRC
$443M
| $77.5K | ﹤0.01% |
4,415
-473
| -10% | -$8.4K |
|
3380
First Business Financial Services
FBIZ
$601M
| $77.2K | ﹤0.01% |
1,693
+111
| +7% | +$4.69K |
|
3381
OR Royalties Inc
OR
$6.15B
| $77K | ﹤0.01% |
4,159
-1
| -0% | -$17 |
|
3382
Aldeyra Therapeutics
ALDX
$86.9M
| $76.7K | ﹤0.01% |
14,229
+10,201
| +253% | +$48.6K |
|
3383
SIGA Technologies
SIGA
$207M
| $76.4K | ﹤0.01% |
11,322
-63,525
| -85% | -$555K |
|
|
DRD
3384
DRDGold
DRD
$2.06B
| $75.1K | ﹤0.01% |
7,787
-28,925
| -79% | -$267K |
|
3385
Utah Medical Products
UTMD
$230M
| $74.7K | ﹤0.01% |
1,117
+566
| +103% | +$38.4K |
|
3386
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
| $74.6K | ﹤0.01% |
3,472
| – | – |
|
3387
Stoneridge
SRI
$201M
| $74.5K | ﹤0.01% |
6,662
-10,994
| -62% | -$157K |
|
3388
iShares MSCI Sweden ETF
EWD
$585M
| $74.2K | ﹤0.01% |
1,709
+20
| +1% | +$815 |
|
3389
StealthGas
GASS
$343M
| $74K | ﹤0.01% |
10,873
-15,490
| -59% | -$100K |
|
3390
Designer Brands
DBI
$312M
| $73.8K | ﹤0.01% |
9,996
-255,972
| -96% | -$1.79M |
|
3391
Oil-Dri
ODC
$1.27B
| $73.7K | ﹤0.01% |
2,136
-5,448
| -72% | -$177K |
|
3392
AB InBev
BUD
$158B
| $73.6K | ﹤0.01% |
1,111
-3,529
| -76% | -$218K |
|
3393
ArcelorMittal
MT
$55.2B
| $72.7K | ﹤0.01% |
2,768
-33,247
| -92% | -$761K |
|
3394
Microvision
MVIS
$89.7M
| $72.7K | ﹤0.01% |
4,250
-1,304
| -23% | -$20.3K |
|
3395
Lifeway Foods
LWAY
$377M
| $72K | ﹤0.01% |
2,778
+1,155
| +71% | +$19.3K |
|
3396
Schwab US Dividend Equity ETF
SCHD
$108B
| $71.7K | ﹤0.01% |
2,544
-1,356
| -35% | -$36.9K |
|
3397
Parke Bancorp
PKBK
$413M
| $71.6K | ﹤0.01% |
3,427
+1,235
| +56% | +$23.8K |
|
3398
Greif Class B
GEF.B
$4.22B
| $71.4K | ﹤0.01% |
1,023
+37
| +4% | +$2.44K |
|
3399
Southern First Bancshares
SFST
$612M
| $70.4K | ﹤0.01% |
2,066
+568
| +38% | +$18.3K |
|
3400
Anika Therapeutics
ANIK
$283M
| $70.2K | ﹤0.01% |
2,841
-149
| -5% | -$3.86K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2024 Portfolio in Review
As of Q3 2024, BNP Paribas Financial Markets held 4,296 positions worth $149B, up 21% from $123B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets's Q3 2024 filing shows 266 new, 2,153 increased, 1,264 reduced and 157 closed positions. Its largest new stake was Ferguson: 319,382 shares worth $63.4M. The largest sale was Visa, an estimated $805M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q3 2024 buy was Ferguson: 319,382 shares worth $63.4M.
- BNP Paribas Financial Markets added most to NVIDIA in Q3 2024, an estimated $672M increase.
- BNP Paribas Financial Markets's biggest Q3 2024 reduction was Visa, cutting an estimated $805M.
- BNP Paribas Financial Markets fully exited Lam Research in Q3 2024, selling an estimated $482M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $149B portfolio in Q3 2024.
- BNP Paribas Financial Markets opened 266 new positions and closed 157 in Q3 2024.
- BNP Paribas Financial Markets's portfolio value rose 21% quarter-over-quarter to $149B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2024, filed 13 Nov 2024.